Evidence map›Paper›PMID 25156888›Full record

ArticleAngewandte Chemie (International ed. in English)2014

Optogenetic engineering: light-directed cell motility.

Robert M Hughes, David S Lawrence

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Tools of the trade: studying actin in zebrafish.Histochemistry and cell biology · 2020
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Phototriggered Secretion of Membrane Compartmentalized Bioactive Agents.Angewandte Chemie (International ed. in English) · 2016
    Article
  12. Optogenetic apoptosis: light-triggered cell death.Angewandte Chemie (International ed. in English) · 2015
    Article
  13. Optimizing optogenetic constructs for control over signaling and cell behaviours.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2015
    Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Robert M HughesDepartment of Chemistry, Division of Chemical Biology and Medicinal Chemistry, and Department of Pharmacology, University of North Carolina, Chapel Hill, NC 27599 (USA).
David S Lawrence

Funding

Spatiotemporal Control of Tumor Cell SignalingR01CA159189 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LAWRENCE, DAVID S. · 2011 to 2015
$1.5M
NCI NIH HHS 1R01CA159189NCI NIH HHS R01 CA159189
6 · The paper itself

Abstract

Genetically encoded, light-activatable proteins provide the means to probe biochemical pathways at specific subcellular locations with exquisite temporal control. However, engineering these systems in order to provide a dramatic jump in localized activity, while retaining a low dark-state background remains a significant challenge. When placed within the framework of a genetically encodable, light-activatable heterodimerizer system, the actin-remodelling protein cofilin induces dramatic changes in the F-actin network and consequent cell motility upon illumination. We demonstrate that the use of a partially impaired mutant of cofilin is critical for maintaining low background activity in the dark. We also show that light-directed recruitment of the reduced activity cofilin mutants to the cytoskeleton is sufficient to induce F-actin remodeling, formation of filopodia, and directed cell motility.

Indexed as

LightOptogeneticsActin CytoskeletonActinsAmino Acid SubstitutionAnimalsCell Line, TumorCell MovementCofilin 1CryptochromesLuminescent ProteinsMiceMicroscopy, ConfocalPseudopodiaRed Fluorescent ProteinActinsCofilin 1CryptochromesLuminescent ProteinsRed Fluorescent Proteincell motilitycofilinF-actinoptogeneticsprotein design

Identifiers

PMID25156888
PMCPMC4196877

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.